| Literature DB >> 15551208 |
Ming Qiao1, Mundrigi Ashok, Kristen A Bernard, Gustavo Palacios, Z Hong Zhou, W Ian Lipkin, T Jake Liang.
Abstract
No specific vaccine for West Nile virus (WNV) is currently available for human use. In the present study, we describe the generation of WNV-like particles (WNV-LPs) in insect cells by use of recombinant baculoviruses expressing the WNV structural proteins prME or CprME. BALB/c mice immunized with purified WNV-LPs developed WNV-specific antibodies that had potent neutralizing activities. Mice immunized with prME-like particles (prME-LPs) showed no morbidity or mortality after challenge with WNV. Immunization with prME-LPs can induce sterilizing immunity without producing any evidence of viremia or viral RNA in the spleen or brain. These results suggest that WNV-LPs hold promise as a vaccine candidate for WNV infection.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15551208 DOI: 10.1086/425933
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226